Immunoprecise Antibodies Ltd
IPA1.745USD
+0.105+6.40%
取引時間 （ET）15分遅れの株価
80.54M時価総額
損失額直近12ヶ月PER
詳細情報 Immunoprecise Antibodies Ltd 企業名
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
企業情報
企業コードIPA
会社名Immunoprecise Antibodies Ltd
上場日Jan 30, 1987
最高経営責任者「CEO」Dr. Jennifer Lynne Bath, Ph.D.
従業員数- -
証券種類Ordinary Share
決算期末Jan 30
本社所在地Industrious 823 Congress Ave Suite 300
都市AUSTIN
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号78701
電話番号16048060626
ウェブサイトhttps://www.ipatherapeutics.com/
企業コードIPA
上場日Jan 30, 1987
最高経営責任者「CEO」Dr. Jennifer Lynne Bath, Ph.D.
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Dr. Ilse Roodink, Ph.D.
Dr. Ilse Roodink, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Director
Director
--
--
Mr. Barry A. Springer
Mr. Barry A. Springer
Independent Director
Independent Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Dr. Ilse Roodink, Ph.D.
Dr. Ilse Roodink, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Director
Director
--
--
収益内訳
通貨: CAD更新時刻: Sun, Jul 6
通貨: CAD更新時刻: Sun, Jul 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
事業別CAD
会社名
収益
比率
Project revenue
5.57M
90.59%
Product sales revenue
501.00K
8.15%
Cryo storage revenue
78.00K
1.27%
地域別CAD
会社名
収益
比率
United States of America
2.88M
46.90%
Europe
2.72M
44.19%
Australia
383.00K
6.23%
Other
112.00K
1.82%
Canada
53.00K
0.86%
事業別
地域別
事業別CAD
会社名
収益
比率
Project revenue
5.57M
90.59%
Product sales revenue
501.00K
8.15%
Cryo storage revenue
78.00K
1.27%
株主
更新時刻: Sat, Jul 12
更新時刻: Sat, Jul 12
株主統計
種類
株主統計
株主統計
比率
Charmquark TWEE
7.92%
Ingalls & Snyder LLC (Asset Management)
6.02%
Susquehanna International Group, LLP
1.52%
Bath (Jennifer Lynne)
1.08%
Two Sigma Investments, LP
0.20%
Other
83.26%
株主統計
株主統計
比率
Charmquark TWEE
7.92%
Ingalls & Snyder LLC (Asset Management)
6.02%
Susquehanna International Group, LLP
1.52%
Bath (Jennifer Lynne)
1.08%
Two Sigma Investments, LP
0.20%
Other
83.26%
種類
株主統計
比率
Corporation
7.99%
Investment Advisor/Hedge Fund
6.14%
Investment Advisor
1.82%
Individual Investor
1.34%
Research Firm
0.35%
Hedge Fund
0.26%
Family Office
0.04%
Venture Capital
0.04%
Other
82.02%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
45
8.20M
23.19%
+1.46M
2025Q1
45
6.32M
13.81%
+742.61K
2024Q4
45
4.34M
9.53%
-1.30M
2024Q3
46
5.39M
19.68%
+72.87K
2024Q2
48
5.12M
19.96%
-156.62K
2024Q1
50
5.14M
20.20%
-196.19K
2023Q4
58
5.33M
20.96%
+124.72K
2023Q3
50
4.91M
19.67%
-438.42K
2023Q2
53
5.01M
20.08%
-885.29K
2023Q1
54
5.19M
20.83%
-561.90K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Charmquark TWEE
1.83M
4%
-1.30M
-41.62%
Dec 31, 2024
Ingalls & Snyder LLC (Asset Management)
2.76M
6.03%
+1.20M
+76.65%
Mar 31, 2025
Susquehanna International Group, LLP
703.00K
1.54%
+703.00K
--
Mar 31, 2025
Bath (Jennifer Lynne)
498.12K
1.09%
+237.30K
+90.98%
Dec 16, 2024
Two Sigma Investments, LP
90.58K
0.2%
+90.58K
--
Mar 31, 2025
Virtu Americas LLC
57.85K
0.13%
+37.09K
+178.66%
Mar 31, 2025
CIBC World Markets Inc.
41.20K
0.09%
--
--
Mar 31, 2025
Thoroughbred Financial Services LLC
40.00K
0.09%
+40.00K
--
Mar 31, 2025
Group One Trading, L.P.
30.06K
0.07%
+30.00K
+49180.33%
Mar 31, 2025
Levine (Mitchell S)
30.00K
0.07%
+10.00K
+50.00%
Aug 01, 2024
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
